Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine
Authors:
- Julia Mester-TonczarJMJulia Mester-Tonczar
- Johannes WinklerJWJohannes Winkler
- Patrick EinzingerPEPatrick Einzinger
- Ena HasimbegovicEHEna Hasimbegovic
- Nina KastnerNKNina Kastner
- Dominika LukovicDLDominika Lukovic
- Katrin ZlabingerKZKatrin Zlabinger
- Andreas SpannbauerASAndreas Spannbauer
- Denise TraxlerDTDenise Traxler
- Sandor BatkaiSBSandor Batkai
- Thomas ThumThomas Thum
- Mariann GyöngyösiMariann Gyöngyösi
Open Access
- 14 August 2020
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 10 (8) , 1180
Abstract
Anti-fibrotic therapies are of increasing interest to combat cardiac remodeling and heart failure progression. Recently, anti-fibrotic circular RNAs (circRNAs) have been identified in human and rodent cardiac tissue. In vivo (rodent) experiments proved cardiac anti-fibrotic effects of the natural compounds bufalin and lycorine by downregulating miRNA-671-5p, associated with a theoretic increase in the tissue level of circRNA CDR1as. Accordingly, we hypothesized that both anti-fibrotic drugs may inhibit focal myocardial fibrosis of the remodeled left ventricle (LV) also in a translational large animal model of heart failure (HF). Domestic pigs were repeatedly treated with subcutaneous injections of either bufalin, lycorine, or saline, (n = 5/group) between days 7–21 post acute myocardial infarction (AMI). At the 2-month follow-up, both bufalin and lycorine led to significantly reduced cardiac fibrosis. Bufalin treatment additionally led to smaller end-diastolic volumes, higher LV ejection fraction (EF), and increased expression of CDR1as of the AMI region. Elevated tissue levels of the circRNA CDR1as in the AMI region of the pig heart correlated significantly with LV and right ventricular EF, LV stroke volume, and negatively with infarct size. In conclusion, we successfully identified the circRNA CDR1as in pig hearts and show a significant association with improved LV and RV function by anti-fibrotic therapies in a translational animal model of HF.Keywords
Funding Information
- FIBROTARGETs EU project (602904)
This publication has 38 references indexed in Scilit:
- miRNA signature of unfolded protein response in H9c2 rat cardiomyoblastsCell & Bioscience, 2014
- Pathological Ventricular RemodelingCirculation, 2013
- Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and AutophagyInternational Journal of Molecular Sciences, 2013
- Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replicationVirology Journal, 2011
- miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNAThe EMBO Journal, 2011
- TGF-β signaling in fibrosisGrowth Factors, 2011
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Mechanisms of postinfarct left ventricular remodelingDrug Discovery Today: Disease Mechanisms, 2007
- Regulation of collagen degradation in the rat myocardium after infarctionJournal of Molecular and Cellular Cardiology, 1995
- Identification of functional angiotensin II receptors on rat cardiac fibroblasts.Circulation, 1993